Pasar al contenido principal

Multi-omics approaches to unravel the molecular vulnerabilities of human diseases

RYC2021-031799-I

•
Nombre agencia financiadora Agencia Estatal de Investigación
Acrónimo agencia financiadora AEI
Programa Programa Estatal para Desarrollar, Atraer y Retener Talento
Subprograma Subprograma Estatal de Incorporación
Convocatoria Ramón y Cajal
Año convocatoria 2021
Plan Estatal 2021-2023 Plan Estatal de Investigación Científica y Técnica y de Innovación
Centro beneficiario AGENCIA ESTATAL CONSEJO SUPERIOR DE INVESTIGACIONES CIENTIFICAS (CSIC)

Resultados relacionados

Resultados totales (Incluyendo duplicados): 5
Encontrada(s) 1 página(s)

DIGITAL.CSIC. Repositorio Institucional del CSIC
Publicación Artículo científico (JournalArticle)

CRISPR/dCAS9-mediated DNA demethylation screen identifies functional epigenetic determinants of colorectal cancer

  • Tejedor, Juan Ramón
  • Peñarroya, Alfonso
  • Gancedo-Verdejo, Javier
  • Santamarina-Ojeda, Pablo
  • Pérez, Raúl F.
  • López-Tamargo, Sara
  • Díez-Borge, Ana
  • Alba-Linares, Juan J.
  • González-Del-Rey, Nerea
  • Urdinguio, Rocío G.
  • Mangas, Cristina
  • Roberti, Annalisa
  • López, Virginia
  • Morales-Ruiz, Teresa
  • Ariza, Rafael R.
  • Roldán-Arjona, Teresa
  • Meijón, Mónica
  • Valledor, Luis
  • Cañal, María Jesús
  • Fernández-Martínez, Daniel
  • Fernández-Hevia, María
  • Jiménez-Fonseca, Paula
  • García-Flórez, Luis J.
  • Fernández, Agustín F.
  • Fraga, Mario F.
[Background]: Promoter hypermethylation of tumour suppressor genes is frequently observed during the malignant transformation of colorectal cancer (CRC). However, whether this epigenetic mechanism is functional in cancer or is a mere consequence of the carcinogenic process remains to be elucidated., [Results]: In this work, we performed an integrative multi-omic approach to identify gene candidates with strong correlations between DNA methylation and gene expression in human CRC samples and a set of 8 colon cancer cell lines. As a proof of concept, we combined recent CRISPR-Cas9 epigenome editing tools (dCas9-TET1, dCas9-TET-IM) with a customized arrayed gRNA library to modulate the DNA methylation status of 56 promoters previously linked with strong epigenetic repression in CRC, and we monitored the potential functional consequences of this DNA methylation loss by means of a high-content cell proliferation screen. Overall, the epigenetic modulation of most of these DNA methylated regions had a mild impact on the reactivation of gene expression and on the viability of cancer cells. Interestingly, we found that epigenetic reactivation of RSPO2 in the tumour context was associated with a significant impairment in cell proliferation in p53-/- cancer cell lines, and further validation with human samples demonstrated that the epigenetic silencing of RSPO2 is a mid-late event in the adenoma to carcinoma sequence., [Conclusions]: These results highlight the potential role of DNA methylation as a driver mechanism of CRC and paves the way for the identification of novel therapeutic windows based on the epigenetic reactivation of certain tumour suppressor genes., This work was supported by Health Institute Carlos III (Plan Nacional de I + D + I) co-funding FEDER (PI18/01527 and PI21/01067 to M.F.F. and A.F.F.; COV00624 to J.R.T. and M.F.F.), the Spanish Association Against Cancer (PROYE18061FERN to M.F.F.), the Asturias Government (PCTI) co-funding 2018-2023/FEDER (IDI/2018/146 and IDI/2021/000077 to M.F.F.), The Junta de Andalucía co-funding FEDER (PY20_00051 to T.R.-A.), ISPA-Jannsen (2021-048-INTRAMURAL NOV-TEVAR to J.R.T.) and the European Commission NextGenerationEU, through CSIC’s Global Health Platform (PTI Salud Global) and the Spanish Ministry of Science and Innovation through the Recovery, Transformation and Resilience Plan (SGL2021-03-39 and SGL2021-03-040). J.R.T. is supported by the Spanish Ministry of Science and Innovation (IJC2018-036825-I and RYC2021-031799-I). A.P. is supported by the ISCIII (FI19/00085). J.G.V. is supported by the Spanish Ministry of Universities (FPU20/04659). R.F.P. (BP17-114) and P.S.M. (BP17-165) are supported by the Severo Ochoa program. R.G.U. is supported by the Centro de Investigación Biomédica en Red de Enfermedades Raras (CIBERER). J.J.A.L. is supported by the AECC fellowship (PRDAS21642ALBA). A.R. is supported by CSIC (SOLAUT_00038505 SGL2103040)., Peer reviewed
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publicación Artículo científico (JournalArticle)

Multi-omic integration of DNA methylation and gene expression data reveals molecular vulnerabilities in glioblastoma

  • Santamarina-Ojeda, Pablo
  • Tejedor, Juan Ramón
  • Pérez, Raúl F.
  • López, Virginia
  • Roberti, Annalisa
  • Mangas, Cristina
  • Fernández, Agustín F.
  • Fraga, Mario F.
Glioblastoma (GBM) is one of the most aggressive types of cancer and exhibits profound genetic and epigenetic heterogeneity, making the development of an effective treatment a major challenge. The recent incorporation of molecular features into the diagnosis of patients with GBM has led to an improved categorization into various tumour subtypes with different prognoses and disease management. In this work, we have exploited the benefits of genome-wide multi-omic approaches to identify potential molecular vulnerabilities existing in patients with GBM. Integration of gene expression and DNA methylation data from both bulk GBM and patient-derived GBM stem cell lines has revealed the presence of major sources of GBM variability, pinpointing subtype-specific tumour vulnerabilities amenable to pharmacological interventions. In this sense, inhibition of the AP-1, SMAD3 and RUNX1/RUNX2 pathways, in combination or not with the chemotherapeutic agent temozolomide, led to the subtype-specific impairment of tumour growth, particularly in the context of the aggressive, mesenchymal-like subtype. These results emphasize the involvement of these molecular pathways in the development of GBM and have potential implications for the development of personalized therapeutic approaches., The research reported in this publication was supported by the Spanish Association Against Cancer (AECC, PROYE18061FERN to MFF), the Asturias Government (PCTI) co-funding 2018-2022/FEDER (IDI/2018/146 and IDI/2021/077 to MFF), the European Commission-NextGenerationEU, through CSIC's Global Health Platform (PTI Salud Global) and the Spanish Ministry of Science and Innovation through the Recovery, Transformation and Resilience Plan (GL2021-03-39 and GL2021-03-040 to MFF) and the Health Research Institute Carlos III (Plan Nacional de I + D + I) co-funding FEDER (PI18/01527 and PI21/01067 to MFF and AFF). PS-O and RFP are supported by the Severo Ochoa programme (BP17-165 and BP17-114 respectively). JRT is supported by a Ramón y Cajal contract from the Spanish Ministry of Science and Innovation (RYC2021-031799-I). AR is supported by the PTI Salud Global. VL and CM are supported by the IUOPA-Obra Social Cajastur-Liberbank., Peer reviewed
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publicación Artículo científico (JournalArticle)

A multiomic atlas of the aging hippocampus reveals molecular changes in response to environmental enrichment

  • Pérez, Raúl F.
  • Tezanos, Patricia
  • Peñarroya, Alfonso
  • González-Ramón, A.
  • Urdinguio, Rocío G.
  • Gancedo-Verdejo, Javier
  • Tejedor, Juan Ramón
  • Santamarina-Ojeda, Pablo
  • Alba-Linares, Juan J.
  • Sainz-Ledo, Lidia
  • Roberti, Annalisa
  • López, Virginia
  • Mangas, Cristina
  • Moro, María
  • Cintado, Elisa
  • Muela Martínez, Pablo
  • Rodríguez-Santamaría, Mar
  • Ortea, Ignacio
  • Iglesias-Rey, Ramón
  • Castilla-Silgado, Juan
  • Tomás-Zapico, Cristina
  • Iglesias-Gutiérrez, Eduardo
  • Fernández-García, Benjamín
  • Sánchez-Mut, José Vicente
  • Trejo, José L.
  • Fernández, Agustín F.
  • Fraga, Mario F.
Aging involves the deterioration of organismal function, leading to the emergence of multiple pathologies. Environmental stimuli, including lifestyle, can influence the trajectory of this process and may be used as tools in the pursuit of healthy aging. To evaluate the role of epigenetic mechanisms in this context, we have generated bulk tissue and single cell multi-omic maps of the male mouse dorsal hippocampus in young and old animals exposed to environmental stimulation in the form of enriched environments. We present a molecular atlas of the aging process, highlighting two distinct axes, related to inflammation and to the dysregulation of mRNA metabolism, at the functional RNA and protein level. Additionally, we report the alteration of heterochromatin domains, including the loss of bivalent chromatin and the uncovering of a heterochromatin-switch phenomenon whereby constitutive heterochromatin loss is partially mitigated through gains in facultative heterochromatin. Notably, we observed the multi-omic reversal of a great number of aging-associated alterations in the context of environmental enrichment, which was particularly linked to glial and oligodendrocyte pathways. In conclusion, our work describes the epigenomic landscape of environmental stimulation in the context of aging and reveals how lifestyle intervention can lead to the multi-layered reversal of aging-associated decline., This work was supported by the Spanish Association Against Cancer (PROYE18061FERN to MFF), the Asturias Government (PCTI) co-funding 2018-2023/FEDER (IDI/2018/146 and IDI/2021/000077 to MFF), the Health Institute Carlos III (Plan Nacional de I + D + I) co-funding FEDER (PI18/01527 and PI21/01067 to MFF and AFF), CIBERER Acciones Cooperativas y Complementarias Intramurales (ACCI20-35 to MFF), the Fundación General CSIC (0348_CIE_6_E to MFF), the ISCIII (COV00624 to JRT and MFF), ISPA and the Asociación Galbán (2021-052-INTRAMUR GALBAN-GOURR to RGU), ISPA-Jannsen (2021-048-INTRAMURAL NOV-TEVAR to JRT), ELITE SPORTS 2015 (FUO-19-073 to BFG), CSIC (202020E092 to MFF), and the European Commission NextGenerationEU, through CSIC’s Global Health Platform (PTI Salud Global) and the Spanish Ministry of Science and Innovation through the Recovery, Transformation and Resilience Plan (SGL2021-03-39 and SGL2021-03-040). The laboratory of JVSM is supported by the Spanish Ministry of Science and Innovation (PID-2019-111240RA-I00), and the CSIC Interdisciplinary Thematic Platform (PTI + ) NEURO-AGING+ (PTI-NEURO-AGING + ). AR is supported by CSIC (SOLAUT_00038505 SGL2103040). JRT is supported by a Ramon y Cajal contract from the Spanish Ministry of Science and Innovation (RYC2021-031799-I). RFP (BP17-114) and PSO (BP17-165) are supported by the Severo Ochoa program. RGU is supported by the Centro de Investigación Biomédica en Red de Enfermedades Raras (CIBERER). JGV is supported by the Spanish Ministry of Universities (FPU20/04659). AGR is supported by the Spanish Ministry of Science and Innovation (PRE2020-093389). We also acknowledge support from the Institute of Oncology of Asturias (IUOPA, supported by Obra Social Cajastur Liberbank, Spain), the Health Research Institute of Asturias (ISPA-FINBA) and Consorcio Centro de Investigación Biomédica en Red (CIBERER-ISCIII)., Peer reviewed
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publicación Artículo científico (JournalArticle)

Age-dependent effect of environmental enrichment on the neural 3D chromatin interactome

  • Gancedo-Verdejo, Javier
  • Urdinguio, Rocío G.
  • Tejedor, Juan Ramón
  • Pérez, Raúl F.
  • Peñarroya, Alfonso
  • Santamarina-Ojeda, Pablo
  • Roberti, Annalisa
  • Kefauver, Jennifer M.
  • Álvarez Díaz, Carlota
  • Rodríguez-Santamaría, Mar
  • Trejo, José L.
  • Tomás Daza, Laureano
  • Rovirosa, Llorenç
  • Javierre, Biola M.
  • Fernández, Agustín F.
  • Fraga, Mario F.
Aging is a multifactorial biological process resulting in physiological and cellular decline. However, our understanding of age-related changes in 3D genome organization and the effect of external interventions on this process remains limited. Here, we describe alterations in the landscape of the 3D chromatin interactome upon aging, utilizing the low-input promoter capture Hi-C (liCHi-C) technique with mouse hippocampal neurons. We also integrated liCHi-C data with RNA sequencing (RNA-seq) data to identify functional implications. Furthermore, we assessed the effect of exposure to environmental enrichment (EE). Remarkably, our results demonstrate an age-dependent modulation of promoter interactions and expression with EE, with aging-like changes induced in young mice upon EE, likely associated with brain maturation, while age-related alterations were reverted in old mice, leading to a partial rejuvenation of aged mouse hippocampi. These findings reveal a dynamic behavior of the neuronal 3D chromatin structure over time, which can be modulated by external interventions., We are grateful to the Scientific and Technical Services (STSs) of the University of Oviedo, including the animal facilities of the University of Oviedo, and especially to Ana Cristina Salas Bustamante for her positive contribution to the project. This work has been funded by Instituto de Salud Carlos III (ISCIII) (grants PI21/01067 and PI24/00641 to M.F.F. and A.F.F.) and co-funded by the European Union, the Spanish Association against Cancer (Fundación científica de la AECC) (PRYGN235109FERN to M.F.F.), the Asturias government (PCTI) co-funding 2018–2023/Fondo Europeo de Desarrollo Regional (FEDER) from the European Union (IDI/2021/000077 and IDI/2024/000744 to M.F.F.), Spanish Biomedical Research Network in Rare Diseases (CIBERER) Acciones Cooperativas y Complementarias Intramurales (ACCI20-34-U766 to M.F.F.), Health Research Institute of the Principality of Asturias (ISPA) and the Asociación Galbán (2021-052-INTRAMUR GALBAN-GOURR to R.G.U. and 2023-165-GALBAN-TEVAJ to J.R.T.), ISPA-Jannsen (2021-048-INTRAMURAL NOV-TEVAR to J.R.T.), the eprObes project funded by the European Union through the Horizon Europe Framework Programme (GA 101080219), and ERA-NET TRANSCAN-3 initiative (JTC 2023) (AC24/00163 to M.F.F.). The laboratory of B.M.J. is supported by FEDER/Spanish Ministry of Science and Innovation (PID2021-125277OB-I00). J.G.-V. is supported by the Spanish Ministry of Universities (FPU20/04659). R.G.U. is supported by the Centro de Investigación Biomédica en Red (CIBER). J.R.T. is supported by a Ramon y Cajal contract from the Spanish Ministry of Science and Innovation (RYC2021-031799-I). R.F.P. (BP17-114) and P.S.-O. (BP17-165) are supported by the Severo Ochoa program. A.R. is supported by the Spanish National Research Council (CSIC) (SOLAUT_00038505 SGL2103040) and eprObes project (GA 101080219). J.M.K. is supported by an ARISTOS fellowship (ARISTOS has received funding from the European Union’s Horizon Europe Research and Innovation Programme under the Marie Sklodowska-Curie grant agreement no. 101081334). L.T.-D. is supported by the FPI Fellowship (PRE2019-088005). L.R. is supported by an AGAUR FI fellowship (2019FI-B00017). B.M.J. is supported by the Instituto de Salud Carlos III (ISCIII) (CP22/00127). We also acknowledge support from the Institute of Oncology of Asturias (IUOPA, supported by Obra Social Cajastur Liberbank, Spain), the Health Research Institute of Asturias (ISPA-FINBA), and Consorcio Centro de Investigación Biomédica en Red de Enfermedades Raras (CIBERER-ISCIII)., Peer reviewed
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publicación Artículo científico (JournalArticle)

Epigenetic clocks as quantitative readouts of epigenetic drift

  • Pérez, Raúl F.
  • Tejedor, Juan Ramón
  • Fernández, Agustín F.
  • Fraga, Mario F.
Epigenetic drift leads to gradual alterations of the epigenome that have been harnessed (particularly at the DNA-methylation level) to build epigenetic clocks. However, the functional significance of the signals these clocks capture remains unclear. We discuss the evolution of the concept of epigenetic drift and examine how epigenetic clocks have emerged as quantitative readouts of this phenomenon., The authors were supported by the Spanish Association Against Cancer (PRYGN235109FERN to M.F.F.), the Asturias Government (PCTI) co-funding 2018-2023/FEDER (IDI/2021/000077 and IDI/2024/000744 to M.F.F.), the ISCIII (PI21/01067 and PI24/00641 to M.F.F. and A.F.F. and co-funded by the European Union), the CIBERER, Acciones Cooperativas y Complementarias Intramurales (ACCI20-34-U766 to M.F.F. and ACCI23-13-766 to J.R.T.), ISPA and the Galbán Association (2023-165-GALBAN-TEVAJ to J.R.T.), the eprObes project funded by the European Union through the Horizon Europe Framework Programme (GA 101080219), and ERA-NET TRANSCAN-3 initiative (JTC 2023) (AC24/00163 to M.F.F.). J.R.T. is supported by a Ramon y Cajal fellowship from the Spanish Ministry of Science and Innovation (RYC2021-031799-I). We also acknowledge support from the Institute of Oncology of Asturias (IUOPA, supported by Obra Social Cajastur-Liberbank, Spain), the Health Research Institute of Asturias (ISPA-FINBA) and the Consorcio Centro de Investigación Biomédica en Red de Enfermedades Raras (CIBERER-ISCIII)., Peer reviewed